These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12014814)

  • 21. A randomised trial of the cost effectiveness of buprenorphine as an alternative to methadone maintenance treatment for heroin dependence in a primary care setting.
    Harris AH; Gospodarevskaya E; Ritter AJ
    Pharmacoeconomics; 2005; 23(1):77-91. PubMed ID: 15693730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A controlled comparison of buprenorphine and clonidine for acute detoxification from opioids.
    Cheskin LJ; Fudala PJ; Johnson RE
    Drug Alcohol Depend; 1994 Oct; 36(2):115-21. PubMed ID: 7851278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Buprenorphine retention in primary care.
    Stein MD; Cioe P; Friedmann PD
    J Gen Intern Med; 2005 Nov; 20(11):1038-41. PubMed ID: 16307630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute interactions of buprenorphine with intravenous cocaine and morphine: an investigational new drug phase I safety evaluation.
    Teoh SK; Mendelson JH; Mello NK; Kuehnle J; Sintavanarong P; Rhoades EM
    J Clin Psychopharmacol; 1993 Apr; 13(2):87-99. PubMed ID: 8463453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and side-effects of buprenorphine in the clinical management of heroin addiction.
    Lange WR; Fudala PJ; Dax EM; Johnson RE
    Drug Alcohol Depend; 1990 Aug; 26(1):19-28. PubMed ID: 2209411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Buprenorphine versus methadone maintenance for opioid dependence.
    Kosten TR; Schottenfeld R; Ziedonis D; Falcioni J
    J Nerv Ment Dis; 1993 Jun; 181(6):358-64. PubMed ID: 8501457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short-term outcomes after brief ambulatory opioid detoxification with buprenorphine in young heroin users.
    Gandhi DH; Jaffe JH; McNary S; Kavanagh GJ; Hayes M; Currens M
    Addiction; 2003 Apr; 98(4):453-62. PubMed ID: 12653815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and tolerability of the switch from buprenorphine to buprenorphine/naloxone in an Italian addiction treatment centre.
    Stimolo C; Favero VD; Zecchinato G; Buson R; Cusin D; Pellachin P; Simonetto P
    Clin Drug Investig; 2010; 30 Suppl 1():27-31. PubMed ID: 20450243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A controlled trial of buprenorphine treatment for opioid dependence.
    Johnson RE; Jaffe JH; Fudala PJ
    JAMA; 1992 May; 267(20):2750-5. PubMed ID: 1578593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Network therapy: decreased secondary opioid use during buprenorphine maintenance.
    Galanter M; Dermatis H; Glickman L; Maslansky R; Sellers MB; Neumann E; Rahman-Dujarric C
    J Subst Abuse Treat; 2004 Jun; 26(4):313-8. PubMed ID: 15182896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Public sector low threshold office-based buprenorphine treatment: outcomes at year 7.
    Bhatraju EP; Grossman E; Tofighi B; McNeely J; DiRocco D; Flannery M; Garment A; Goldfeld K; Gourevitch MN; Lee JD
    Addict Sci Clin Pract; 2017 Feb; 12(1):7. PubMed ID: 28245872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Open-label trial of an injection depot formulation of buprenorphine in opioid detoxification.
    Sobel BF; Sigmon SC; Walsh SL; Johnson RE; Liebson IA; Nuwayser ES; Kerrigan JH; Bigelow GE
    Drug Alcohol Depend; 2004 Jan; 73(1):11-22. PubMed ID: 14687955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Buprenorphine effects on morphine- and cocaine-induced subjective responses by drug-dependent men.
    Teoh SK; Mello NK; Mendelson JH; Kuehnle J; Gastfriend DR; Rhoades E; Sholar W
    J Clin Psychopharmacol; 1994 Feb; 14(1):15-27. PubMed ID: 8151000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness and cost-effectiveness of unsupervised buprenorphine-naloxone for the treatment of heroin dependence in a randomized waitlist controlled trial.
    Dunlop AJ; Brown AL; Oldmeadow C; Harris A; Gill A; Sadler C; Ribbons K; Attia J; Barker D; Ghijben P; Hinman J; Jackson M; Bell J; Lintzeris N
    Drug Alcohol Depend; 2017 May; 174():181-191. PubMed ID: 28371689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Desipramine in opioid-dependent cocaine abusers maintained on buprenorphine vs methadone.
    Oliveto AH; Feingold A; Schottenfeld R; Jatlow P; Kosten TR
    Arch Gen Psychiatry; 1999 Sep; 56(9):812-20. PubMed ID: 12884887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Buprenorphine treatment for opioid dependence: the relative efficacy of daily, twice and thrice weekly dosing.
    Marsch LA; Bickel WK; Badger GJ; Jacobs EA
    Drug Alcohol Depend; 2005 Feb; 77(2):195-204. PubMed ID: 15664721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of high-dose intravenous buprenorphine in experienced opioid abusers.
    Umbricht A; Huestis MA; Cone EJ; Preston KL
    J Clin Psychopharmacol; 2004 Oct; 24(5):479-87. PubMed ID: 15349002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized controlled trial of buprenorphine in the management of short-term ambulatory heroin withdrawal.
    Lintzeris N; Bell J; Bammer G; Jolley DJ; Rushworth L
    Addiction; 2002 Nov; 97(11):1395-404. PubMed ID: 12410780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Counseling and directly observed medication for primary care buprenorphine maintenance: a pilot study.
    Moore BA; Barry DT; Sullivan LE; Oʼconnor PG; Cutter CJ; Schottenfeld RS; Fiellin DA
    J Addict Med; 2012 Sep; 6(3):205-11. PubMed ID: 22614936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of heroin addicts using buprenorphine.
    Kosten TR; Morgan C; Kleber HD
    Am J Drug Alcohol Abuse; 1991 Jun; 17(2):119-28. PubMed ID: 1862786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.